<unk>  (EV/MMC), known by the tentative brand name Lutofollin, is a combination medication of estradiol valerate (EV), an estrogen, and<unk><unk>  (MMC; superlutin<unk> , a progestin, which was developed for potential use as a once-a-month combined injectable contraceptive but was never marketed. It contained 10 mg EV and 60 mg MMC in 1 mL oil solution and was intended for administration by intramuscular injection once every 4 weeks.
Estradiol valerate/methenmadinone caproate
Estradiol enantate/algestone acetophenide
Estradiol undecylate/norethisterone enanthate
Estradiol valerate/prasterone enanthate
Estradiol valerate/gestonorone caproate
Estradiol valerate/norethisterone enantate
Estradiol valerate/testosterone enanthate
Estradiol benzoate/estradiol phenylpropionate